Effects of GM-CSF on Dendritic Cells and Regulatory T cells in Parkinson’s Disease Patients and Models of Parkinson’s Disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading

  2017cited by this paper
• Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

  2017cited by this paper
• GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease.

  2017cited by this paper
• Exploring Braak’s Hypothesis of Parkinson’s Disease

  2017cited by this paper
• Comparison of neutrophil–lymphocyte ratio (NLR) in Parkinson’s disease subtypes

  2017cited by this paper
• Regulation of Murine Natural Killer Cell Development

  2017cited by this paper
• Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling

  2017cited by this paper
• A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease

  2017cited by this paper
• Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice

  2017cited by this paper
• Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson’s disease

  2016cited by this paper
• Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice

  2016cited by this paper
• Progression of non-motor symptoms in Parkinson's disease among different age populations: A two-year follow-up study.

  2016cited by this paper
• Oxidative and nitrosative stress in serum of patients with Parkinson’s disease

  2016cited by this paper
• Microglial M1/M2 polarization and metabolic states

  2016influential reference
• Antimicrobial peptides and wound healing: biological and therapeutic considerations

  2016cited by this paper
• Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson’s Disease

  2016cited by this paper
• The mechanism and control of Jagged1 expression in Sertoli cells

  2016cited by this paper
• Current and experimental treatments of Parkinson disease: A guide for neuroscientists

  2016cited by this paper
• Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.

  2016cited by this paper
• First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers

  2016cited by this paper
• Tolerogenic dendritic cells

  2016influential reference
• Transcriptome profiling of human FoxP3+ regulatory T cells.

  2016cited by this paper
• Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial

  2016cited by this paper
• Altered dendritic cell subset distribution in patients with Parkinson's disease: Impact of CMV serostatus.

  2016cited by this paper
• CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.

  2016cited by this paper
• Metabolism Is Central to Tolerogenic Dendritic Cell Function

  2016cited by this paper
• Biological role of granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) on cells of the myeloid lineage

  2016cited by this paper
• Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.

  2016influential reference
• Tolerogenic dendritic cells show gene expression profiles that are different from those of immunogenic dendritic cells in DBA/1 mice

  2016cited by this paper
• Neuroinflammation Induces Neurodegeneration.

  2016cited by this paper
• CCR4 and its ligands: from bench to bedside.

  2015cited by this paper
• Related Mechanisms of Antibody Somatic Hypermutation and Class Switch Recombination

  2015cited by this paper
• Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice

  2015influential reference
• Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease

  2015cited by this paper
• Roles of microglia in brain development, tissue maintenance and repair.

  2015influential reference
• Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.

  2015cited by this paper
• Genome‐wide expression and methylation profiles reveal candidate genes and biological processes underlying synovial inflammatory tissue of patients with osteoarthritis

  2015cited by this paper
• Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

  2015cited by this paper
• Bee Venom Phospholipase A2, a Novel Foxp3+ Regulatory T Cell Inducer, Protects Dopaminergic Neurons by Modulating Neuroinflammatory Responses in a Mouse Model of Parkinson’s Disease

  2015cited by this paper
• Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

  2015cited by this paper
• Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients

  2015influential reference
• Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction

  2015cited by this paper
• Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man

  2015influential reference
• The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.

  2015influential reference
• Regulatory dendritic cells in autoimmunity: A comprehensive review.

  2015cited by this paper
• Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease.

  2015influential reference
• Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease

  2015cited by this paper
• Granulocyte-Macrophage Colony Stimulating Factor Exerts Protective and Immunomodulatory Effects in Cortical Trauma

  2015cited by this paper
• Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders

  2015cited by this paper
• Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease.

  2015cited by this paper
• A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson's disease model mice.

  2014cited by this paper
• Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.

  2014cited by this paper
• Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): results from a phase I-II clinical trial.

  2014cited by this paper
• The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration.

  2014cited by this paper
• T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases

  2014cited by this paper
• Tolerogenic dendritic cells and their applications in transplantation

  2014cited by this paper
• Neuroinflammation and M2 microglia: the good, the bad, and the inflamed

  2014cited by this paper
• Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models

  2014cited by this paper
• Transcriptional and epigenetic regulation of T-helper lineage specification

  2014cited by this paper
• Derivation of Injury-Responsive Dendritic Cells for Acute Brain Targeting and Therapeutic Protein Delivery in the Stroke-Injured Rat

  2013cited by this paper
• Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

  2013cited by this paper
• Ly6C+Ly6G− Myeloid‐derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury

  2013cited by this paper
• [Epidemiology of Parkinson's disease].

  2013influential reference
• The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

  2013cited by this paper
• Association of Parkinson disease with structural and regulatory variants in the HLA region.

  2013cited by this paper
• Basophils and allergic inflammation.

  2013cited by this paper
• Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia

  2013cited by this paper
• OX40L/Jagged1 Cosignaling by GM-CSF–Induced Bone Marrow-Derived Dendritic Cells Is Required for the Expansion of Functional Regulatory T Cells

  2013influential reference
• GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

  2013influential reference
• Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity

  2013cited by this paper
• Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?

  2013cited by this paper
• Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease

  2013cited by this paper
• Neutrophil recruitment and function in health and inflammation

  2013influential reference
• Changes in Chemokine Receptor Expression of Regulatory T Cells After Ex Vivo Culture

  2012cited by this paper
• Sargramostim (GM‐CSF) for Induction of Remission in Crohn's Disease: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Systematic Review of Randomized Trials

  2012cited by this paper
• Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease

  2012influential reference
• Neurotoxin-based models of Parkinson's disease.

  2012influential reference
• Association between Parkinson's disease and the HLA‐DRB1 locus

  2012cited by this paper
• The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions

  2012cited by this paper
• Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease

  2012cited by this paper
• CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease

  2012influential reference
• Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.

  2012influential reference
• Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease

  2012cited by this paper
• Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease

  2012influential reference
• CD4+T Cells: Differentiation and Functions

  2012cited by this paper
• Association of Parkinson's disease with infections and occupational exposure to possible vectors

  2012influential reference
• Phosphorylated alpha-Synuclein in Parkinson's Disease

  2012cited by this paper
• Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity

  2012cited by this paper
• Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum

  2012influential reference
• Reduced T helper and B lymphocytes in Parkinson's disease.

  2012influential reference
• Inflammation and adaptive immunity in Parkinson's disease.

  2012cited by this paper
• Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson's disease: role of regulatory T cells.

  2012cited by this paper
• Murine Motor and Behavior Functional Evaluations for Acute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Intoxication

  2011influential reference
• Regulation of the immune response and inflammation by histamine and histamine receptors.

  2011cited by this paper
• RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

  2011cited by this paper
• Neuropathology in Mice Expressing Mouse Alpha-Synuclein

  2011cited by this paper
• α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

  2011cited by this paper
• The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.

  2011cited by this paper
• The Role of Microglia in the Healthy Brain

  2011cited by this paper

• No citing papers are available for this paper.